Does limiting fluoroquinolone antibiotics help prevent Clostridioides difficile infection in hospitals?

Clostridioides difficile infection (CDI) is the most common healthcare-associated infection in the United States, and antibiotic use is the single biggest risk factor for developing it ⁶. Among all antibiotics, fluoroquinolones are specifically linked to a very high risk of infection ⁶. Because of this strong link, hospitals have implemented programs to restrict or limit the use of these drugs to protect patients.

What the research says

Research shows that fluoroquinolones, along with cephalosporins and clindamycin, confer the highest risk for developing CDI among all antibiotic classes ⁶. This specific danger is so well documented that it has led to the creation of the FIRST trial, which studied how to best restrict fluoroquinolone prescriptions to prevent CDI ².

Hospitals use electronic health record tools to enforce these restrictions, but the specific rules often need to be adapted to fit the local hospital context ². Studies indicate that while fluoroquinolones are effective for some bacterial infections, their use significantly disrupts the gut bacteria needed to keep C. difficile in check ⁶.

Other sources highlight that C. difficile is particularly resistant to fluoroquinolones in many regions, making these drugs a poor choice for treating other infections when safer alternatives exist ⁵. A clinical scoring system developed to predict CDI recurrence even includes fluoroquinolone use as a key variable, further confirming its role as a major risk factor ⁷.

What to ask your doctor

• Are fluoroquinolones necessary for my specific infection, or is there a safer antibiotic option?
• What is the risk of developing C. difficile if I take this specific antibiotic?
• Does my hospital have a protocol to limit the use of high-risk antibiotics like fluoroquinolones?
• If I must take a fluoroquinolone, what steps can I take to protect my gut health?